San Francisco Chronicle

How safe is Monsanto’s Roundup? Jury verdict gives cause for pause

- By Nathan Donley and Carey Gillam Nathan Donley, Ph.D., is a senior scientist in the Center for Biological Diversity’s environmen­tal health program. Carey Gillam, a journalist, is winner of the Society of Environmen­tal Journalist­s 2018 Rachel Carson Book

It’s been three weeks since a San Francisco jury found that exposure to Monsanto’s Roundup herbicides contribute­d to former school groundskee­per Dewayne “Lee” Johnson’s terminal cancer and awarded a stunning $289 million in damages to the 46-yearold father. And during that time, we’ve seen repeated assertions from the pesticide giant and its allies that, in fact, the jury was wrong and the weed killer of choice for millions of Americans is perfectly safe.

Monsanto Vice President Scott Partridge repeated the familiar mantra: Hundreds of scientific studies, as well as reviews by regulatory agencies across the globe, including the U.S. Environmen­tal Protection Agency, have found that glyphosate — the active ingredient in Roundup — does not cause cancer. Monsanto’s new owner, Bayer AG, went further. Bayer CEO Werner Baumann told investors that the jury was just flat-out “wrong” and that Bayer would work to ensure that sales of the weed-killing products were not interrupte­d. “More than 800 scientific studies and reviews” support glyphosate safety, he told investors.

Unchalleng­ed, the carefully honed talking points sound impressive and conclusive — exactly as intended.

But in the wake of the jury’s award, many people across the United States who have been spraying the pesticide on their lawns and gardens for years doubt those reassuring words. And with good reason.

Corporate assurances of safety leave out one important word — a word that is critically important to anyone who wants to make an informed decision about the cancer risk associated with Roundup and the hundreds of other glyphosate-based herbicides on the market.

That word is “independen­t,” as in “independen­t scientific studies and reviews.”

As was laid out in the trial, there is a wealth of evidence, much of it from within Monsanto’s own internal documents, detailing how much of the research suggesting that Roundup is safe has been orchestrat­ed and/or influenced by Monsanto and its chemical industry allies.

But truly independen­t research has shown that there is reason for concern. As Roundup use on U.S. farms, residentia­l lawns and gardens has soared from roughly 40 million pounds a year in the 1990s to nearly 300 million pounds in recent years, the dangers of the chemical have been documented in numerous peer-reviewed studies.

It was those independen­t and peer-reviewed works that convinced the cancer research arm of the World Health Organizati­on to determine that glyphosate is a probable human carcinogen. In the wake of that WHO finding, California added glyphosate to the state’s list of cancer-causing chemicals.

Monsanto’s response to that 2015 classifica­tion was more manipulate­d science. An “independen­t review” of glyphosate showed up in a peer-reviewed scientific journal decrying the IARC classifica­tion. The review not only was titled as being independen­t, but declared that no Monsanto employee had any involvemen­t in the writing of it.Yet the company’s internal emails, turned over in discovery associated with the litigation, revealed that a Monsanto scientist in fact aggressive­ly edited and reviewed the analysis prior to its publicatio­n.

That was but one of multiple examples detailed in the unsealed documents of similar efforts, referred to by Monsanto’s own employees as “ghostwriti­ng.”

The EPA has sided with Monsanto over independen­t scientists, declaring the pesticide is not likely to cause cancer. By doing so, the agency has ignored the fact that its own Office of Research and Developmen­t expressed unease with the EPA’s handling of the glyphosate evaluation, as did a scientific advisory panel convened by the agency to peer-review the evaluation.

Perhaps not surprising­ly, the trial evidence also included communicat­ions detailing what can only be described as cozy collaborat­ions between Monsanto and certain EPA officials.

Americans deserve better from their regulators, whose priority should be to put the public’s health far before corporate profits.

Instead, it took a brave man dying of cancer and jury of 12 ordinary citizens to step up and face the challenge of taking a hard look at the scientific facts and calling for justice.

 ?? Georges Gobet / AFP / Getty Images 2017 ?? A cancer victim’s court victory over herbicide-maker Monsanto could open the floodgates to a slew of lawsuits, leaving the new German owner Bayer with a buyer’s remorse.
Georges Gobet / AFP / Getty Images 2017 A cancer victim’s court victory over herbicide-maker Monsanto could open the floodgates to a slew of lawsuits, leaving the new German owner Bayer with a buyer’s remorse.
 ?? Josh Edelson / Associated Press ?? A San Francisco jury ordered Monsanto to pay $289 million to Dewayne “Lee” Johnson, a groundskee­per dying of cancer.
Josh Edelson / Associated Press A San Francisco jury ordered Monsanto to pay $289 million to Dewayne “Lee” Johnson, a groundskee­per dying of cancer.

Newspapers in English

Newspapers from United States